Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review

• Main Authors: Ilaria De Benedetto (Author), Silvia Corcione (Author), Carlotta Giambra (Author), Matteo Ferrante (Author), Simone Mornese Pinna (Author), Elisa Zanotto (Author), Alice Palermiti (Author), Francesca Sidoti (Author), Luca Scaglione (Author), Cecilia Grosso (Author), Martina Billi (Author), Tommaso Lupia (Author), Sara Soloperto (Author), Jessica Cusato (Author), Cristina Costa (Author), Antonio D'Avolio (Author), Francesco Giuseppe De Rosa (Author)
• Format: Book
• Published: MDPI AG, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Patients with hematologic malignancies are more likely to develop severe and prolonged SARS-CoV-2 infection, often showing viral persistence despite the use of authorized antivirals. Herein, we report the cases of four patients who received rituximab for different conditions and develo...